Trial NCT01310855

View at ClinicalTrials.gov 
Org. Study IDs: CDR0000696313
Secondary IDs: 2010-021531-13 CRUKE/10/044 UCL-10/0035 ZENECA-ISSRECE00002

Last trial update was posted on 2017-05-31

MeSH Interventions

Cediranib Gefitinib

MeSH Conditions

Glioblastoma

Other Conditions


Stopping Reasons

closed to recruitment early due to AstraZeneca not developing cediranib further

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID